Marshall Wace’s iShares MSCI Emerging Markets ex China ETF EMXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$36.7M Buy
467,057
+454,716
+3,685% +$36.6M 0.04% 470
2025
Q4
$897K Sell
12,341
-167,059
-93% -$11.8M ﹤0.01% 1991
2025
Q3
$12.1M Buy
179,400
+110,432
+160% +$7.14M 0.01% 849
2025
Q2
$4.35M Buy
+68,968
New +$4.01M ﹤0.01% 1210
2025
Q1
Sell
-94,105
Closed -$5.22M 2739
2024
Q4
$5.22M Buy
94,105
+86,413
+1,123% +$5.07M 0.01% 1041
2024
Q3
$470K Sell
7,692
-260,751
-97% -$15.7M ﹤0.01% 1941
2024
Q2
$15.9M Buy
268,443
+206,975
+337% +$11.9M 0.02% 568
2024
Q1
$3.54M Sell
61,468
-207,991
-77% -$11.6M 0.01% 1137
2023
Q4
$14.9M Buy
+269,459
New +$13.9M 0.03% 565
2023
Q3
Sell
-5,200
Closed -$270K 2311
2023
Q2
$270K Buy
+5,200
New +$264K ﹤0.01% 2171
2022
Q3
Sell
-43,167
Closed -$2.06M 3450
2022
Q2
$2.06M Buy
+43,167
New +$2.3M ﹤0.01% 1964

Other funds holding EMXC

Marshall Wace's EMXC Position: Q1 2026 in Review

Marshall Wace increased its iShares MSCI Emerging Markets ex China ETF (EMXC) stake by 3,685% in Q1 2026, buying an estimated $36.6M and bringing the position to 467,057 shares worth $36.7M. The position accounts for 0.04% of the portfolio, ranked #470.

Marshall Wace first reported a position in EMXC in Q2 2022 and has held it in 11 quarters since. 926 funds tracked by Wall St. Rank hold EMXC as of Q1 2026.

  • Marshall Wace held 467,057 shares of iShares MSCI Emerging Markets ex China ETF worth $36.7M as of Q1 2026.
  • Marshall Wace bought 454,716 iShares MSCI Emerging Markets ex China ETF shares in Q1 2026, an estimated $36.6M.
  • iShares MSCI Emerging Markets ex China ETF made up 0.04% of Marshall Wace's portfolio in Q1 2026, its #470 holding.
  • Marshall Wace first reported a position in iShares MSCI Emerging Markets ex China ETF in Q2 2022 and has held it in 11 quarters since.
  • 926 funds tracked by Wall St. Rank held iShares MSCI Emerging Markets ex China ETF as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.